You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港交所(00388.HK):共18間生物科技公司透過第18A章上市 籌資440億元
阿思達克 05-26 15:10
港交所(00388.HK)上市主管陳翊庭出席生物科技線上研討會時表示,港交所在2018年4月引入上市規則第18A章以來,共有18間生物科技公司根據該新章在港上市,共籌集資金440億元。而部分公司其後亦有進行增發,為研發等業務發展不斷尋找新資金,額外籌資270億元。

她指,生物科技公司在產品及治療範疇有更完整的覆蓋,18間已上市企業中有聚焦藥品、生物製藥以至醫療器械公司,行業亦有基因治療等新板塊,認為可令投資者有更多元化的投資機會。

陳翊庭提到,看到圍繞第18A章建立而成的生態系統,有更多專業人士如投資銀行家、律師、研究員等分析板塊,有助提升行業質素及維持長遠的可持續發展。她又稱,上市科需要不斷檢視規則及做法,以促進板塊的發展,交易所在引入新章兩周年之際檢視了運作,並於早前發出了新指引。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account